ANNE GREEN: Open Payments
NPI 1588057806 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 75 payments from 12 companies in 2025. Trend: 2023 $714 · 2024 $583 · 2025 $1,406
Food & beverage: $1,287Education: $119
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $318 |
| Neurocrine BioSciences, Inc. | 10 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $206 |
| E.R. Squibb & Sons, L.L.C. | 12 | $164 |
| Janssen Pharmaceuticals, Inc | 15 | $139 |
| Lundbeck LLC | 6 | $102 |
| Alkermes, Inc. | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: INGREZZA, CAPLYTA, COBENFY, INVEGA SUSTENNA, UZEDY, HETLIOZ, AUSTEDO XR, ARISTADA.
Industry payments across TN — which companies pay providers there.
